ReviewMolecular cancer2018

Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.

Shang-Gin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.